GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » Return-on-Tangible-Equity

Eckert & Ziegler SE (XTER:EUZ) Return-on-Tangible-Equity : 19.00% (As of Mar. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Eckert & Ziegler SE's annualized net income for the quarter that ended in Mar. 2024 was €33.9 Mil. Eckert & Ziegler SE's average shareholder tangible equity for the quarter that ended in Mar. 2024 was €178.7 Mil. Therefore, Eckert & Ziegler SE's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 was 19.00%.

The historical rank and industry rank for Eckert & Ziegler SE's Return-on-Tangible-Equity or its related term are showing as below:

XTER:EUZ' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 18.23   Med: 24.46   Max: 29.72
Current: 21.14

During the past 13 years, Eckert & Ziegler SE's highest Return-on-Tangible-Equity was 29.72%. The lowest was 18.23%. And the median was 24.46%.

XTER:EUZ's Return-on-Tangible-Equity is ranked better than
84.58% of 759 companies
in the Medical Devices & Instruments industry
Industry Median: 1.23 vs XTER:EUZ: 21.14

Eckert & Ziegler SE Return-on-Tangible-Equity Historical Data

The historical data trend for Eckert & Ziegler SE's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE Return-on-Tangible-Equity Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.15 22.09 29.72 24.29 18.23

Eckert & Ziegler SE Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.21 21.36 32.04 16.26 19.00

Competitive Comparison of Eckert & Ziegler SE's Return-on-Tangible-Equity

For the Medical Devices subindustry, Eckert & Ziegler SE's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's Return-on-Tangible-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's Return-on-Tangible-Equity falls into.



Eckert & Ziegler SE Return-on-Tangible-Equity Calculation

Eckert & Ziegler SE's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=26.3/( (115.06+173.398 )/ 2 )
=26.3/144.229
=18.23 %

Eckert & Ziegler SE's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=33.948/( (173.398+183.959)/ 2 )
=33.948/178.6785
=19.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Eckert & Ziegler SE  (XTER:EUZ) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Eckert & Ziegler SE Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE (XTER:EUZ) Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, D-13125
Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific and industrial use. It is primarily engaged in the business activities of cancer therapy, industrial radiometry, and nuclear-medical imaging. The business segments of the group are Isotope products; Medical and Holding company. The company generates maximum revenue from Isotope products segment. Geographically, it derives a majority of revenue from Europe and also has a presence in North America, Asia-Pacific, and other regions.
Executives
Dr. Andreas Eckert Supervisory Board
Frank Perschmann Supervisory Board
Dr. Hakim Bouterfa Board of Directors
Prof. Dr. Wolfgang Maennig Supervisory Board
Dr. Harald Hasselmann Board of Directors

Eckert & Ziegler SE (XTER:EUZ) Headlines

No Headlines